We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$94.7M
AUM Growth
+$1.57M
Cap. Flow
-$2.28M
Cap. Flow %
-2.4%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TRVN
Trevena, Inc.
TRVN
+$1.49M
2
BIND
BIND THERAPEUTICS INC
BIND
+$789K

Sector Composition

Rank Sector Weight
1 Healthcare 85.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
1
Cartesian Therapeutics
RNAC
$218M
$27.4M 28.95%
64,138
– –
TRVN
2
DELISTED
Trevena, Inc.
TRVN
$13.9M 14.63%
3,286
-347
-10% -$1.49M
TTOO
3
DELISTED
T2 Biosystems, Inc
TTOO
$13.6M 14.34%
375
– –
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
$10.1M 10.64%
246,076
– –
FATE icon
5
Fate Therapeutics
FATE
$275M
$7.72M 8.15%
2,473,186
– –
OCUL icon
6
Ocular Therapeutix
OCUL
$1.83B
$6.86M 7.24%
998,713
– –
PULM icon
7
Pulmatrix
PULM
$6.1M
$5.95M 6.28%
18,040
– –
ATYR
8
aTyr Pharma
ATYR
$47.4M
$5.81M 6.14%
130,571
– –
DARE icon
9
Dare Bioscience
DARE
$17.4M
$3.44M 3.63%
27,396
– –
BIND
10
DELISTED
BIND THERAPEUTICS INC
BIND
– –
-2,018,253
Closed -$789K

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q3 2016 Portfolio in Review

As of Q3 2016, Polaris Venture Management Co V held 10 positions worth $94.7M, up 1.7% from $93.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V's Q3 2016 filing shows 1 reduced and 1 closed positions. The largest sale was Trevena, Inc., an estimated $1.49M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, up from 83% a quarter earlier.

  • Polaris Venture Management Co V's biggest Q3 2016 reduction was Trevena, Inc., cutting an estimated $1.49M.
  • Polaris Venture Management Co V fully exited BIND THERAPEUTICS INC in Q3 2016, selling an estimated $789K.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $94.7M portfolio in Q3 2016.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q3 2016.
  • Polaris Venture Management Co V's portfolio value rose 1.7% quarter-over-quarter to $94.7M.

Based on Polaris Venture Management Co V's 13F filing for Q3 2016, filed 9 Nov 2016.